Search Results
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS, 51-100 바 명단 공개
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpg로고 - https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS STELLT DIE LISTE DER BARS VON 51-100 VOR
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogo – https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS UNVEILS LIST OF BARS RANKED FROM 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogo - https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS UNVEILS LIST OF BARS RANKED FROM 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogo - https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS DIVULGA LISTA DE BARES CLASSIFICADOS DE 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogotipo -
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS DIVULGA LISTA DE BARES CLASSIFICADOS DE 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogotipo -
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS DÉVOILE LA LISTE DES BARS CLASSÉS DE 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogo - https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS SVELA LA CLASSIFICA DEI BAR NELLE POSIZIONI 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogo - https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS PRESENTA LA LISTA DE LOS BARES CLASIFICADOS DEL 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogotipo -
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS PRESENTA LA LISTA DE LOS BARES CLASIFICADOS DEL 51-100
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogotipo -
More news about: 50 Best
Sep 24, 2025, 03:00 ET THE WORLD'S 50 BEST BARS UNVEILS LIST OF BARS RANKED FROM 51-100 FOR 2025
https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpgLogo - https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg
More news about: 50 Best
Sep 24, 2025, 02:45 ET New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies
https://ir.genmab.com/static-files/9d491b72-bb0b-4e46-a792-dee6c29aaf7d Accessed August 13, 2025.Novartis. Data on file.###
More news about: Novartis Pharmaceuticals Corporation
Sep 23, 2025, 08:00 ET BroadbandOne® Partners with FulAir Wireless to Power Connectivity for Louisiana's Oil & Gas Corridor and Beyond
www.BroadbandOne.com. About BroadbandOne BroadbandOne (BB1) is an innovative wireless network operator and value added partner deploying carrier grade IP connectivity services to enterprises in Tier 2 and 3 and rural markets in the U.S. BB1 is one of the nation's largest holders of 5G spectrum in
More news about: BroadbandOne
Sep 22, 2025, 21:09 ET 기컴, 브랜드 창립 22주년 기념: '미니 PC의 대명사, 기컴'
https://www.amazon.com/stores/GEEKOM/page/6B6CA43F-BB72-44D4-870E-C0A33FF26AC3?is_byline_deeplink=true&deeplink=E2FD84C5-08E5-499F-911C-93C69F317282&redirect_store_id=6B6CA43F-BB72-44D4-870E-C0A33FF26AC3&lp_asin=B0DSPB26NK&ref_=ast_bln&store_ref=bl_ast_dp_미니 PC에 관해서는
More news about: GEEKOM
Sep 22, 2025, 16:06 ET AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
15.62 % BB
More news about: AllianceBernstein National Municipal Income Fund, Inc.
Sep 22, 2025, 16:06 ET AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
14.78 % BB
More news about: AllianceBernstein Global High Income Fund, Inc.
Sep 22, 2025, 03:14 ET 同類第一潛力：維立志博自免創新藥LBL-047在美國獲批臨床
候選藥物的差異化臨床管線，其中6款已成功進入臨床階段，4款主要產品均處於全球臨床進度領先的候選藥物之列。我們採用科學驅動的研發方法，已成功建立涵蓋抗體發現及工程、體內及體外療效評估以及成藥性評估的綜合研發能力。我們亦開發了包括LeadsBody™平臺（CD3 T-Cell Engager平臺）、X-body™平臺（4-1BB Engager平臺）、TOPiKinectics™（ADC技術平臺）在內的專有技術平臺。我們的技術平臺是我們持續創新的基石，並已通過雙特異性抗體組合的臨床結果得到驗證。我們成功建立起了在早期研發、轉化醫學、臨床開發、CMC以及業務拓展方面無縫銜接的自主能力。我們候選藥物的創新性質及競爭優勢，配合我們全球視野、積極主動的策略及高效的臨床驗證使我們成為頭部行業參與者及風險資本備受歡迎的合作夥伴。更多資訊請訪問：
More news about: 維立志博
Sep 22, 2025, 00:15 ET First-in-Class Potential! FDA Clears IND Application for LBL-047, an Anti-BDCA2/TACI Bispecific Fusion Protein Developed by Leads Biolabs
have also developed multiple proprietary technology platforms, including LeadsBody™ platform (a CD3 T-cell engager platform), X-body™ platform (a 4-1BB engager platform), TOPiKinectics™ (ADC platform), which serve as the cornerstone for our continued innovation and have been validated by the clinical
More news about: Leads Biolabs
Sep 19, 2025, 08:00 ET Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
commercial stages and includes several in-house discovered programs, including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 × 4-1BB bispecific antibody), ATG-031 (CD24-targeting macrophage activator), and ATG-042 (oral PRMT5-MTA inhibitor). Antengene has also developed AnTenGager™,
More news about: Antengene Corporation Limited
Sep 18, 2025, 21:39 ET 2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment
which uses lentivirus as a gene vector to transfect autologous T cells. The CAR contains a fully human scFv, CD8a hinge and transmembrane domain, and 4-1BB co-stimulatory molecule and CD3ζactivation domains. Based on rigorous molecular structure screening and comprehensive in vitro and in vivo functional
More news about: IASO Bio
Sep 16, 2025, 11:00 ET Call for Entries: MotorTrend, QNX, and Vector Announce Fourth Annual Software-Defined Vehicle Innovator Awards
BlackBerry Limited (NYSE: BB; TSX: BB), whose technology is used by countless automakers around the world, and Vector, a leader in the development of automotive software and tools, today
More news about: MotorTrend Group
Sep 15, 2025, 17:31 ET Bispecific Antibodies in Oncology Market Forecast to Surge Over the Next Decade | DelveInsight
Oncology PD-1 × VEGF, PD-1 × CTLA-4, PD-L1 × 4-1BB, TIGIT × PDL1, and others are the prominent targets of bispecific antibodies in NSCLC, whereas targets such as DLL4 × VEGF-A, PD-L1 × VEGF-A, PD-1/IL-2α, Claudin 18.2 (CLDN18.2)/4-1BB, BCMA × CD3, and others are in other cancers. Promising
More news about: DelveInsight Business Research, LLP
Sep 15, 2025, 10:00 ET Glac Biotech、プロバイオティクス株CP-9で米国食品医薬品局のGRAS認証を取得
Awards）においてファイナリストに選出されており、腸内環境の健康維持や免疫調節における役割について研究が行われています。FDAのGRAS認証取得により、CP-9はGlac Biotechの製品ポートフォリオを拡充し、既存株であるBifidobacterium lactis BB-12と並んで、乳児およびファミリー向け栄養市場に貢献することが期待されています。 拡大するプロバイオティクスおよびポストバイオティクス製品のポートフォリオ Glac Biotechの最初のGRAS通知株であるMP108は、2021年にニュートライングリディエンツ・アワードの最終候補に選出され、2023年にFDAの認証を取得しました。同株は、アジアで初めて乳児向け用途として認証されたプロバイオティクス株となります。臨床データおよび安全性データに基づき、MP108は1食当たり最大10⁹
More news about: Glac Biotech
Sep 15, 2025, 10:00 ET 글락바이오텍 프로바이오틱 균주 CP-9, FDA GRAS 승인 획득
뉴트라 인그리디언츠 어워드(NutraIngredients Awards) 최종 후보에 오른 적도 있으며 그간 장 건강과 면역 조절력에 대한 연구가 진행되었다. CP-9가 FDA GRAS 지위를 획득함에 따라 글락 바이오텍은 포트폴리오를 확대하여 비피도박테리움 락티스 BB-12와 같은 기존 균주와 함께 영유아 및 가족 영양 시장 공략에도 박차를 가할 계획이다. 프로바이오틱스 솔루션과 포스트바이오틱스 솔루션 다각화 글락 바이오텍의 첫 GRAS 인증 균주인 MP108은 2021년 인그리디언츠 어워드 최종 후보에 올랐고 2023년에 FDA
More news about: Glac Biotech
Sep 15, 2025, 10:00 ET Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9
Glac Biotech's portfolio and is expected to serve the infant and family nutrition markets alongside established strains such as Bifidobacterium lactis BB-12. Growing Portfolio of Probiotic and Postbiotic Solutions Glac Biotech's first GRAS-notified strain, MP108, was shortlisted for
More news about: Glac Biotech